Download PDF
Semin Respir Crit Care Med 2021; 42(06): 759-770
DOI: 10.1055/s-0041-1736459
Review Article

The Immune Response to Respiratory Viruses: From Start to Memory

Tom D.Y. Reijnders   *
1   Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
,
Alex R. Schuurman   *
1   Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
,
Tom van der Poll
1   Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
2   Division of Infectious Diseases, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Biomedical research has long strived to improve our understanding of the immune response to respiratory viral infections, an effort that has become all the more important as we live through the consequences of a pandemic. The disease course of these infections is shaped in large part by the actions of various cells of the innate and adaptive immune systems. While these cells are crucial in clearing viral pathogens and establishing long-term immunity, their effector mechanisms may also escalate into excessive, tissue-destructive inflammation detrimental to the host. In this review, we describe the breadth of the immune response to infection with respiratory viruses such as influenza and respiratory syncytial virus. Throughout, we focus on the host rather than the pathogen and try to describe shared patterns in the host response to different viruses. We start with the local cells of the airways, onto the recruitment and activation of innate and adaptive immune cells, followed by the establishment of local and systemic memory cells key in protection against reinfection. We end by exploring how respiratory viral infections can predispose to bacterial superinfection.

Keywords

immune response - respiratory viruses - viral infection

* These authors contributed equally




Publication History

Article published online:
16 December 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Newton AH, Cardani A, Braciale TJ. The host immune response in respiratory virus infection: balancing virus clearance and immunopathology. Semin Immunopathol 2016; 38 (04) 471-482
    CrossrefPubMedGoogle Scholar
  • 2 Osuchowski MF, Winkler MS, Skirecki T. et al. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med 2021; 9 (06) 622-642
    CrossrefPubMedGoogle Scholar
  • 3 Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell 2021; 184 (07) 1671-1692
    CrossrefPubMedGoogle Scholar
  • 4 Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 2021; 184 (04) 861-880
    CrossrefPubMedGoogle Scholar
  • 5 Whitsett JA, Alenghat T. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat Immunol 2015; 16 (01) 27-35
    CrossrefPubMedGoogle Scholar
  • 6 Barlow PG, Svoboda P, Mackellar A. et al. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One 2011; 6 (10) e25333
    CrossrefPubMedGoogle Scholar
  • 7 Currie SM, Findlay EG, McHugh BJ. et al. The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus. PLoS One 2013; 8 (08) e73659
    CrossrefPubMedGoogle Scholar
  • 8 Wilson SS, Wiens ME, Smith JG. Antiviral mechanisms of human defensins. J Mol Biol 2013; 425 (24) 4965-4980
    CrossrefPubMedGoogle Scholar
  • 9 Kim J, Yang YL, Jang S-H, Jang Y-S. Human β-defensin 2 plays a regulatory role in innate antiviral immunity and is capable of potentiating the induction of antigen-specific immunity. Virol J 2018; 15 (01) 124
    CrossrefPubMedGoogle Scholar
  • 10 Campione E, Cosio T, Rosa L. et al. Lactoferrin as protective natural barrier of respiratory and intestinal mucosa against coronavirus infection and inflammation. Int J Mol Sci 2020; 21 (14) 1-14
    CrossrefPubMedGoogle Scholar
  • 11 Watson A, Madsen J, Clark HW. SP-A and SP-D: dual functioning immune molecules with antiviral and immunomodulatory properties. Front Immunol 2021; 11: 622598
    CrossrefPubMedGoogle Scholar
  • 12 Galani IE, Triantafyllia V, Eleminiadou EE. et al. Interferon-λ mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness. Immunity 2017; 46 (05) 875-890.e6
    CrossrefPubMedGoogle Scholar
  • 13 Hussell T, Bell TJ. Alveolar macrophages: plasticity in a tissue-specific context. Nat Rev Immunol 2014; 14 (02) 81-93
    CrossrefPubMedGoogle Scholar
  • 14 Purnama C, Ng SL, Tetlak P. et al. Transient ablation of alveolar macrophages leads to massive pathology of influenza infection without affecting cellular adaptive immunity. Eur J Immunol 2014; 44 (07) 2003-2012
    CrossrefPubMedGoogle Scholar
  • 15 Schneider C, Nobs SP, Heer AK. et al. Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection. PLoS Pathog 2014; 10 (04) e1004053
    CrossrefPubMedGoogle Scholar
  • 16 Cardani A, Boulton A, Kim TS, Braciale TJ. Alveolar macrophages prevent lethal influenza pneumonia by inhibiting infection of type-1 alveolar epithelial cells. PLoS Pathog 2017; 13 (01) e1006140
    CrossrefPubMedGoogle Scholar
  • 17 Huang F-F, Barnes PF, Feng Y. et al. GM-CSF in the lung protects against lethal influenza infection. Am J Respir Crit Care Med 2011; 184 (02) 259-268
    CrossrefPubMedGoogle Scholar
  • 18 Schneider DJ, Smith KA, Latuszek CE. et al. Alveolar macrophage-derived extracellular vesicles inhibit endosomal fusion of influenza virus. EMBO J 2020; 39 (16) e105057
    CrossrefPubMedGoogle Scholar
  • 19 Harker JA, Lloyd CM. Overlapping and distinct features of viral and allergen immunity in the human lung. Immunity 2021; 54 (04) 617-631
    CrossrefPubMedGoogle Scholar
  • 20 Ho AWS, Prabhu N, Betts RJ. et al. Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells. J Immunol 2011; 187 (11) 6011-6021
    CrossrefPubMedGoogle Scholar
  • 21 Smit JJ, Rudd BD, Lukacs NW. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med 2006; 203 (05) 1153-1159
    CrossrefPubMedGoogle Scholar
  • 22 Wolf AI, Buehler D, Hensley SE. et al. Plasmacytoid dendritic cells are dispensable during primary influenza virus infection. J Immunol 2009; 182 (02) 871-879
    CrossrefPubMedGoogle Scholar
  • 23 Desch AN, Gibbings SL, Goyal R. et al. Flow cytometric analysis of mononuclear phagocytes in nondiseased human lung and lung-draining lymph nodes. Am J Respir Crit Care Med 2016; 193 (06) 614-626
    CrossrefPubMedGoogle Scholar
  • 24 Cruz JLG, Pérez-Girón JV, Lüdtke A. et al. Monocyte-derived dendritic cells enhance protection against secondary influenza challenge by controlling the switch in CD8+ T-cell immunodominance. Eur J Immunol 2017; 47 (02) 345-352
    CrossrefPubMedGoogle Scholar
  • 25 Quinton LJ, Walkey AJ, Mizgerd JP. Integrative physiology of pneumonia. Physiol Rev 2018; 98 (03) 1417-1464
    CrossrefPubMedGoogle Scholar
  • 26 Johansson C, Kirsebom FCM. Neutrophils in respiratory viral infections. Mucosal Immunol 2021; 14 (04) 815-827
    CrossrefPubMedGoogle Scholar
  • 27 Lim K, Hyun YM, Lambert-Emo K. et al. Neutrophil trails guide influenza-specific CD8+ T cells in the airways. Science 2015; 349 (6252): aaa4352
    CrossrefPubMedGoogle Scholar
  • 28 Lim K, Kim T-H, Trzeciak A. et al. In situ neutrophil efferocytosis shapes T cell immunity to influenza infection. Nat Immunol 2020; 21 (09) 1046-1057
    CrossrefPubMedGoogle Scholar
  • 29 Duan M, Hibbs ML, Chen W. The contributions of lung macrophage and monocyte heterogeneity to influenza pathogenesis. Immunol Cell Biol 2017; 95 (03) 225-235
    CrossrefPubMedGoogle Scholar
  • 30 Brandes M, Klauschen F, Kuchen S, Germain RN. A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 2013; 154 (01) 197-212
    CrossrefPubMedGoogle Scholar
  • 31 Seo SU, Kwon HJ, Ko HJ. et al. Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice. PLoS Pathog 2011; 7 (02) e1001304
    CrossrefPubMedGoogle Scholar
  • 32 Goritzka M, Makris S, Kausar F. et al. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J Exp Med 2015; 212 (05) 699-714
    CrossrefPubMedGoogle Scholar
  • 33 Cao W, Taylor AK, Biber RE. et al. Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infection. J Immunol 2012; 189 (05) 2257-2265
    CrossrefPubMedGoogle Scholar
  • 34 Lin KL, Suzuki Y, Nakano H, Ramsburg E, Gunn MD. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol 2008; 180 (04) 2562-2572
    CrossrefPubMedGoogle Scholar
  • 35 van Erp EA, van Kampen MR, van Kasteren PB, de Wit J. Viral infection of human natural killer cells. Viruses 2019; 11 (03) 1-13
    CrossrefPubMedGoogle Scholar
  • 36 Lee AJ, Ashkar AA. The dual nature of type I and type II interferons. Front Immunol 2018; 9: 2061
    CrossrefPubMedGoogle Scholar
  • 37 Damjanovic D, Divangahi M, Kugathasan K. et al. Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection. Am J Pathol 2011; 179 (06) 2963-2976
    CrossrefPubMedGoogle Scholar
  • 38 Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17: 189-220
    CrossrefPubMedGoogle Scholar
  • 39 Nogusa S, Ritz BW, Kassim SH, Jennings SR, Gardner EM. Characterization of age-related changes in natural killer cells during primary influenza infection in mice. Mech Ageing Dev 2008; 129 (04) 223-230
    CrossrefPubMedGoogle Scholar
  • 40 Kaiko GE, Phipps S, Angkasekwinai P, Dong C, Foster PS. NK cell deficiency predisposes to viral-induced Th2-type allergic inflammation via epithelial-derived IL-25. J Immunol 2010; 185 (08) 4681-4690
    CrossrefPubMedGoogle Scholar
  • 41 Abdul-Careem MF, Mian MF, Yue G. et al. Critical role of natural killer cells in lung immunopathology during influenza infection in mice. J Infect Dis 2012; 206 (02) 167-177
    CrossrefPubMedGoogle Scholar
  • 42 Li F, Zhu H, Sun R, Wei H, Tian Z. Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection. J Virol 2012; 86 (04) 2251-2258
    CrossrefPubMedGoogle Scholar
  • 43 Zhou G, Juang SWW, Kane KP. NK cells exacerbate the pathology of influenza virus infection in mice. Eur J Immunol 2013; 43 (04) 929-938
    CrossrefPubMedGoogle Scholar
  • 44 Gasteiger G, Fan X, Dikiy S, Lee SY, Rudensky AY. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 2015; 350 (6263): 981-985
    CrossrefPubMedGoogle Scholar
  • 45 Chang YJ, Kim HY, Albacker LA. et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011; 12 (07) 631-638
    CrossrefPubMedGoogle Scholar
  • 46 Saravia J, You D, Shrestha B. et al. Respiratory syncytial virus disease is mediated by age-variable IL-33. PLoS Pathog 2015; 11 (10) e1005217
    CrossrefPubMedGoogle Scholar
  • 47 Han M, Rajput C, Hong JY. et al. The innate cytokines IL-25, IL-33, and TSLP cooperate in the induction of type 2 innate lymphoid cell expansion and mucous metaplasia in rhinovirus-infected immature mice. J Immunol 2017; 199 (04) 1308-1318
    CrossrefPubMedGoogle Scholar
  • 48 Duerr CU, McCarthy CDA, Mindt BC. et al. Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells. Nat Immunol 2016; 17 (01) 65-75
    CrossrefPubMedGoogle Scholar
  • 49 Han M, Ishikawa T, Bermick JR. et al. IL-1β prevents ILC2 expansion, type 2 cytokine secretion, and mucus metaplasia in response to early-life rhinovirus infection in mice. Allergy Eur J Allergy Clin Immunol 2020; 75 (08) 2001-2015
    PubMedGoogle Scholar
  • 50 Loh Z, Simpson J, Ullah A. et al. HMGB1 amplifies ILC2-induced type-2 inflammation and airway smooth muscle remodelling. PLoS Pathog 2020; 16 (07) e1008651
    CrossrefPubMedGoogle Scholar
  • 51 Califano D, Furuya Y, Roberts S, Avram D, McKenzie ANJ, Metzger DW. IFN-γ increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells. Mucosal Immunol 2018; 11 (01) 209-219
    CrossrefPubMedGoogle Scholar
  • 52 Stier MT, Goleniewska K, Cephus JY. et al. STAT1 represses cytokine-producing group 2 and group 3 innate lymphoid cells during viral infection. J Immunol 2017; 199 (02) 510-519
    CrossrefPubMedGoogle Scholar
  • 53 Vu LD, Siefker D, Jones TL. et al. Elevated levels of type 2 respiratory innate lymphoid cells in human infants with severe respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2019; 200 (11) 1414-1423
    CrossrefPubMedGoogle Scholar
  • 54 Murphy-Schafer AR, Paust S. Divergent mast cell responses modulate antiviral immunity during influenza virus infection. Front Cell Infect Microbiol 2021; 11 (February): 580679
    CrossrefPubMedGoogle Scholar
  • 55 Latreille E, Lee WL. Interactions of influenza and SARS-CoV-2 with the lung endothelium: similarities, differences, and implications for therapy. Viruses 2021; 13 (02) 161
    CrossrefPubMedGoogle Scholar
  • 56 Samarasinghe AE, Melo RCN, Duan S. et al. Eosinophils promote antiviral immunity in mice infected with influenza A virus. J Immunol 2017; 198 (08) 3214-3226
    CrossrefPubMedGoogle Scholar
  • 57 Tiwary M, Rooney RJ, Liedmann S, LeMessurier KS, Samarasinghe AE. Eosinophil responses at the airway epithelial barrier during the early phase of influenza A virus infection in C57BL/6 mice. Cells 2021; 10 (03) 509
    CrossrefPubMedGoogle Scholar
  • 58 Sabbaghi A, Miri SM, Keshavarz M, Mahooti M, Zebardast A, Ghaemi A. Role of γδ T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches. Virol J 2020; 17 (01) 174
    CrossrefPubMedGoogle Scholar
  • 59 Ahrends T, Spanjaard A, Pilzecker B. et al. CD4+ T cell help confers a cytotoxic T cell effector program including coinhibitory receptor downregulation and increased tissue invasiveness. Immunity 2017; 47 (05) 848-861.e5
    CrossrefPubMedGoogle Scholar
  • 60 Ng SL, Teo YJ, Setiagani YA, Karjalainen K, Ruedl C. Type 1 conventional CD103+ dendritic cells control effector CD8+ T cell migration, survival, and memory responses during influenza infection. Front Immunol 2018; 9: 3043
    CrossrefPubMedGoogle Scholar
  • 61 Kim TH, Oh DS, Jung HE, Chang J, Lee HK. Plasmacytoid dendritic cells contribute to the production of ifn-β via tlr7-myd88-dependent pathway and ctl priming during respiratory syncytial virus infection. Viruses 2019; 11 (08) E730
    CrossrefPubMedGoogle Scholar
  • 62 Braciale TJ, Sun J, Kim TS. Regulating the adaptive immune response to respiratory virus infection. Nat Rev Immunol 2012; 12 (04) 295-305
    CrossrefPubMedGoogle Scholar
  • 63 Sun J, Madan R, Karp CL, Braciale TJ. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 2009; 15 (03) 277-284
    CrossrefPubMedGoogle Scholar
  • 64 Jiang L, Yao S, Huang S, Wright J, Braciale TJ, Sun J. Type I IFN signaling facilitates the development of IL-10-producing effector CD8+ T cells during murine influenza virus infection. Eur J Immunol 2016; 46 (12) 2778-2788
    CrossrefPubMedGoogle Scholar
  • 65 Sun J, Dodd H, Moser EK, Sharma R, Braciale TJ. CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat Immunol 2011; 12 (04) 327-334
    CrossrefPubMedGoogle Scholar
  • 66 Weiss KA, Christiaansen AF, Fulton RB, Meyerholz DK, Varga SM. Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection. J Immunol 2011; 187 (06) 3145-3154
    CrossrefPubMedGoogle Scholar
  • 67 Hornick EE, Zacharias ZR, Legge KL. Kinetics and Phenotype of the CD4 T Cell Response to Influenza Virus Infections. Front Immunol 2019; 10: 2351
    CrossrefPubMedGoogle Scholar
  • 68 Brown DM, Lee S, Garcia-Hernandez MdeL, Swain SL. Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection. J Virol 2012; 86 (12) 6792-6803
    CrossrefPubMedGoogle Scholar
  • 69 Wilkinson TM, Li CKF, Chui CSC. et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 2012; 18 (02) 274-280
    CrossrefPubMedGoogle Scholar
  • 70 Topham DJ, DeDiego ML, Nogales A, Sangster MY, Sant A. Immunity to influenza infection in humans. Cold Spring Harb Perspect Med 2021; 11 (03) a038729
    CrossrefPubMedGoogle Scholar
  • 71 Betts RJ, Prabhu N, Ho AWS. et al. Influenza A virus infection results in a robust, antigen-responsive, and widely disseminated Foxp3+ regulatory T cell response. J Virol 2012; 86 (05) 2817-2825
    CrossrefPubMedGoogle Scholar
  • 72 Arpaia N, Green JA, Moltedo B. et al. A distinct function of regulatory T cells in tissue protection. Cell 2015; 162 (05) 1078-1089
    CrossrefPubMedGoogle Scholar
  • 73 Rogers MC, Lamens KD, Shafagati N. et al. CD4+ regulatory T cells exert differential functions during early and late stages of the immune response to respiratory viruses. J Immunol 2018; 201 (04) 1253-1266
    CrossrefPubMedGoogle Scholar
  • 74 Durant LR, Makris S, Voorburg CM, Loebbermann J, Johansson C, Openshaw PJ. Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice. J Virol 2013; 87 (20) 10946-10954
    CrossrefPubMedGoogle Scholar
  • 75 Jansen K, Wirz OF, van de Veen W. et al. Loss of regulatory capacity in T regulatory cells upon rhinovirus infection. J Allergy Clin Immunol 2021; Jun 18;S0091-6749(21)00969–6. DOI: 10.1016/j.jaci.2021.05.045.
    CrossrefPubMedGoogle Scholar
  • 76 Chiu C, Openshaw PJ. Antiviral B cell and T cell immunity in the lungs. Nat Immunol 2015; 16 (01) 18-26
    CrossrefPubMedGoogle Scholar
  • 77 Coro ES, Chang WLW, Baumgarth N. Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J Immunol 2006; 176 (07) 4343-4351
    CrossrefPubMedGoogle Scholar
  • 78 Lam JH, Baumgarth N. The multifaceted B cell response to influenza virus. J Immunol 2019; 202 (02) 351-359
    CrossrefPubMedGoogle Scholar
  • 79 Choi YS, Baumgarth N. Dual role for B-1a cells in immunity to influenza virus infection. J Exp Med 2008; 205 (13) 3053-3064
    CrossrefPubMedGoogle Scholar
  • 80 Jung HE, Lee HK. Host protective immune responses against influenza a virus infection. Viruses 2020; 12 (05) E504
    CrossrefPubMedGoogle Scholar
  • 81 He W, Chen CJ, Mullarkey CE. et al. Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice. Nat Commun 2017; 8 (01) 846
    CrossrefPubMedGoogle Scholar
  • 82 Upasani V, Rodenhuis-Zybert I, Cantaert T. Antibody-independent functions of B cells during viral infections. PLoS Pathog 2021; 17 (07) e1009708
    CrossrefPubMedGoogle Scholar
  • 83 Netea MG, Schlitzer A, Placek K, Joosten LAB, Schultze JL. Innate and adaptive immune memory: an evolutionary continuum in the host's response to pathogens. Cell Host Microbe 2019; 25 (01) 13-26
    CrossrefPubMedGoogle Scholar
  • 84 Kumar BV, Connors TJ, Farber DL, Human T. Human T cell development, localization, and function throughout life. Immunity 2018; 48 (02) 202-213
    CrossrefPubMedGoogle Scholar
  • 85 Wang Z, Wan Y, Qiu C. et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells. Nat Commun 2015; 6: 6833
    CrossrefPubMedGoogle Scholar
  • 86 Pais Ferreira D, Silva JG, Wyss T. et al. Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation. Immunity 2020; 53 (05) 985-1000.e11
    CrossrefPubMedGoogle Scholar
  • 87 Gattinoni L, Speiser DE, Lichterfeld M, Bonini C. T memory stem cells in health and disease. Nat Med 2017; 23 (01) 18-27
    CrossrefPubMedGoogle Scholar
  • 88 Graef P, Buchholz VR, Stemberger C. et al. Serial transfer of single-cell-derived immunocompetence reveals stemness of CD8(+) central memory T cells. Immunity 2014; 41 (01) 116-126
    CrossrefPubMedGoogle Scholar
  • 89 Oliveira G, Ruggiero E, Stanghellini MTL. et al. Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory. Sci Transl Med 2015; 7 (317) 317ra198
    CrossrefPubMedGoogle Scholar
  • 90 Kohlmeier JE, Miller SC, Smith J. et al. The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity 2008; 29 (01) 101-113
    CrossrefPubMedGoogle Scholar
  • 91 Sridhar S, Begom S, Bermingham A. et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med 2013; 19 (10) 1305-1312
    CrossrefPubMedGoogle Scholar
  • 92 Hombrink P, Helbig C, Backer RA. et al. Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells. Nat Immunol 2016; 17 (12) 1467-1478
    CrossrefPubMedGoogle Scholar
  • 93 Kumar BV, Ma W, Miron M. et al. Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Rep 2017; 20 (12) 2921-2934
    CrossrefPubMedGoogle Scholar
  • 94 Turner DL, Bickham KL, Thome JJ. et al. Lung niches for the generation and maintenance of tissue-resident memory T cells. Mucosal Immunol 2014; 7 (03) 501-510
    CrossrefPubMedGoogle Scholar
  • 95 McMaster SR, Wein AN, Dunbar PR. et al. Pulmonary antigen encounter regulates the establishment of tissue-resident CD8 memory T cells in the lung airways and parenchyma. Mucosal Immunol 2018; 11 (04) 1071-1078
    CrossrefPubMedGoogle Scholar
  • 96 Hu Y, Lee Y-T, Kaech SM, Garvy B, Cauley LS. Smad4 promotes differentiation of effector and circulating memory CD8 T cells but is dispensable for tissue-resident memory CD8 T cells. J Immunol 2015; 194 (05) 2407-2414
    CrossrefPubMedGoogle Scholar
  • 97 McMaster SR, Wilson JJ, Wang H, Kohlmeier JE. Airway-resident memory CD8 T cells provide antigen-specific protection against respiratory virus challenge through rapid IFN-γ production. J Immunol 2015; 195 (01) 203-209
    CrossrefPubMedGoogle Scholar
  • 98 Pizzolla A, Nguyen THO, Smith JM. et al. Resident memory CD8+ T cells in the upper respiratory tract prevent pulmonary influenza virus infection. Sci Immunol 2017; 2 (12) eaam6970
    CrossrefPubMedGoogle Scholar
  • 99 Uddbäck I, Cartwright EK, Schøller AS. et al. Long-term maintenance of lung resident memory T cells is mediated by persistent antigen. Mucosal Immunol 2021; 14 (01) 92-99
    CrossrefPubMedGoogle Scholar
  • 100 Slütter B, Van Braeckel-Budimir N, Abboud G, Varga SM, Salek-Ardakani S, Harty JT. Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity. Sci Immunol 2017; 2 (07) eaag2031
    CrossrefPubMedGoogle Scholar
  • 101 Hayward SL, Scharer CD, Cartwright EK. et al. Environmental cues regulate epigenetic reprogramming of airway-resident memory CD8+ T cells. Nat Immunol 2020; 21 (03) 309-320
    CrossrefPubMedGoogle Scholar
  • 102 Wu T, Hu Y, Lee Y-T. et al. Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J Leukoc Biol 2014; 95 (02) 215-224
    CrossrefPubMedGoogle Scholar
  • 103 Krammer F. The human antibody response to influenza A virus infection and vaccination. Nat Rev Immunol 2019; 19 (06) 383-397
    CrossrefPubMedGoogle Scholar
  • 104 Ise W, Fujii K, Shiroguchi K. et al. T follicular helper cell-germinal center B cell interaction strength regulates entry into plasma cell or recycling germinal center cell fate. Immunity 2018; 48 (04) 702-715.e4
    CrossrefPubMedGoogle Scholar
  • 105 Victora GD, Nussenzweig MC. Germinal centers. Annu Rev Immunol 2012; 30: 429-457
    CrossrefPubMedGoogle Scholar
  • 106 Nguyen THO, Koutsakos M, van de Sandt CE. et al. Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients. Nat Commun 2021; 12 (01) 2691
    CrossrefPubMedGoogle Scholar
  • 107 Inoue T, Moran I, Shinnakasu R, Phan TG, Kurosaki T. Generation of memory B cells and their reactivation. Immunol Rev 2018; 283 (01) 138-149
    CrossrefPubMedGoogle Scholar
  • 108 Allie SR, Bradley JE, Mudunuru U. et al. The establishment of resident memory B cells in the lung requires local antigen encounter. Nat Immunol 2019; 20 (01) 97-108
    CrossrefPubMedGoogle Scholar
  • 109 Onodera T, Takahashi Y, Yokoi Y. et al. Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection. Proc Natl Acad Sci U S A 2012; 109 (07) 2485-2490
    CrossrefPubMedGoogle Scholar
  • 110 Kurosaki T, Kometani K, Ise W. Memory B cells. Nat Rev Immunol 2015; 15 (03) 149-159
    CrossrefPubMedGoogle Scholar
  • 111 Gould VMW, Francis JN, Anderson KJ, Georges B, Cope AV, Tregoning JS. Nasal IgA provides protection against human influenza challenge in volunteers with low serum influenza antibody titre. Front Microbiol 2017; 8: 900
    CrossrefPubMedGoogle Scholar
  • 112 Habibi MS, Jozwik A, Makris S. et al; Mechanisms of Severe Acute Influenza Consortium Investigators. Impaired antibody-mediated protection and defective IgA B-cell memory in experimental infection of adults with respiratory syncytial virus. Am J Respir Crit Care Med 2015; 191 (09) 1040-1049
    CrossrefPubMedGoogle Scholar
  • 113 Netea MG, Domínguez-Andrés J, Barreiro LB. et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol 2020; 20 (06) 375-388
    CrossrefPubMedGoogle Scholar
  • 114 Zheng J, Wen L, Yen H-L. et al. Phenotypic and functional characteristics of a novel influenza virus hemagglutinin-specific memory NK cell. J Virol 2021; 95 (12) e00165-21
    CrossrefPubMedGoogle Scholar
  • 115 Martín-Loeches I, Sanchez-Corral A, Diaz E. et al; H1N1 SEMICYUC Working Group. Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest 2011; 139 (03) 555-562
    CrossrefPubMedGoogle Scholar
  • 116 Talbot TR, Poehling KA, Hartert TV. et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med 2005; 118 (03) 285-291
    CrossrefPubMedGoogle Scholar
  • 117 Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198 (07) 962-970
    CrossrefPubMedGoogle Scholar
  • 118 McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol 2014; 12 (04) 252-262
    CrossrefPubMedGoogle Scholar
  • 119 Rynda-Apple A, Robinson KM, Alcorn JF. Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease. Infect Immun 2015; 83 (10) 3764-3770
    CrossrefPubMedGoogle Scholar
  • 120 Tian X, Xu F, Lung WY. et al. Poly I:C enhances susceptibility to secondary pulmonary infections by gram-positive bacteria. PLoS One 2012; 7 (09) e41879
    CrossrefPubMedGoogle Scholar
  • 121 Pittet LA, Hall-Stoodley L, Rutkowski MR, Harmsen AG. Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae . Am J Respir Cell Mol Biol 2010; 42 (04) 450-460
    CrossrefPubMedGoogle Scholar
  • 122 Short KR, Kasper J, van der Aa S. et al. Influenza virus damages the alveolar barrier by disrupting epithelial cell tight junctions. Eur Respir J 2016; 47 (03) 954-966
    CrossrefPubMedGoogle Scholar
  • 123 Sajjan U, Wang Q, Zhao Y, Gruenert DC, Hershenson MB. Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am J Respir Crit Care Med 2008; 178 (12) 1271-1281
    CrossrefPubMedGoogle Scholar
  • 124 Siegel SJ, Roche AM, Weiser JN. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host Microbe 2014; 16 (01) 55-67
    CrossrefPubMedGoogle Scholar
  • 125 Sender V, Hentrich K, Pathak A. et al. Capillary leakage provides nutrients and antioxidants for rapid pneumococcal proliferation in influenza-infected lower airways. Proc Natl Acad Sci U S A 2020; 117 (49) 31386-31397
    CrossrefPubMedGoogle Scholar
  • 126 Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med 2008; 14 (05) 558-564
    CrossrefPubMedGoogle Scholar
  • 127 Verma AK, Bansal S, Bauer C, Muralidharan A, Sun K. Influenza infection induces alveolar macrophage dysfunction and thereby enables noninvasive Streptococcus pneumoniae to cause deadly pneumonia. J Immunol 2020; 205 (06) 1601-1607
    CrossrefPubMedGoogle Scholar
  • 128 Neupane AS, Willson M, Chojnacki AK. et al. Patrolling alveolar macrophages conceal bacteria from the immune system to maintain homeostasis. Cell 2020; 183 (01) 110-125.e11
    CrossrefPubMedGoogle Scholar
  • 129 Roberts S, Salmon SL, Steiner DJ, Williams CM, Metzger DW, Furuya Y. Allergic airway disease prevents lethal synergy of influenza A virus-streptococcus pneumoniae coinfection. MBio 2019; 10 (04) e01335-19
    CrossrefPubMedGoogle Scholar
  • 130 Er JZ, Koean RAG, Ding JL. Loss of T-bet confers survival advantage to influenza-bacterial superinfection. EMBO J 2019; 38 (01) 1-16
    PubMedGoogle Scholar
  • 131 Li N, Fan X, Xu M, Zhou Y, Wang B. Flu virus attenuates memory clearance of Pneumococcus via IFN-γ-dependent Th17 and independent antibody mechanisms. iScience 2020; 23 (12) 101767
    CrossrefPubMedGoogle Scholar